Delivery Order SPE2DR25D3301-SPE2DR26F19CQ
Award Date 12/8/25
Potential Completion Date 12/9/25
Potential Value $1.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for DROXIA 400 mg capsules (60 count) with a ceiling value of $8,085.50. This is a firm fixed-price, non-set-aside contract with a completion deadline of October 31, 2025. The award was issued on October 30, 2025, and the place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Droxidopa 100 mg capsules (90-count units) at a ceiling value of $1,266.73. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for ultimate completion by August 18, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Droxidopa 100 mg capsules (90-count unit). This competitive award, valued at $14,943.40, is structured as a firm fixed price delivery order with a completion date of September 9, 2025. The contract was not designated as a set-aside and represents a procurement of pharmaceutical products for federal medical supply needs. AmerisourceBergen...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Department of Defense Medical Supply Chain on September 29, 2025, for the supply of Droxidopa 100 mg capsules (90-count units) valued at $26,921.20. This award is a firm fixed-price delivery order with no set-aside designation, indicating the contract was competitively awarded. The order is scheduled for completion by September 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The U.S. Defense Logistics Agency (DLA) awarded a $13,920.91 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 90-count packages of the drug DROXIDOPA 100 MG CAPSULE. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, which provides a comprehensive range of pharmaceutical products and medical supplies to support military...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a firm fixed-price delivery order from the Defense Logistics Agency (DLA) valued at $67,481 for the supply of Droxidopa 100 mg capsules (90-count units). The contract was awarded on December 1, 2025, with an ultimate completion date of December 2, 2025, and was not designated as a set-aside procurement. This delivery order represents a single requisition fulfilled under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,705.93 to AmerisourceBergen Drug Corp on July 14, 2025, with an ultimate completion date of July 15, 2025. The delivery order (4568785087) is for pharmaceutical products specified as "DT 1C 2.25X4 700/RL 6RL/BX DHAPCL," to be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This is a firm fixed-price, non-set-aside contract awarded through competitive procurement, consistent with...
- The Defense Logistics Agency awarded a delivery order valued at $30,660.36 to AmerisourceBergen Drug Corp for pharmaceutical products and services on November 27, 2025, with an ultimate completion date of November 28, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place of...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,976.34 to AmerisourceBergen Drug Corp on August 16, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the prime contractor under its existing contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award on September 25, 2025, for $37,329.65 to supply Dovato 50-300 mg tablets (30-count packages). This competitively awarded, firm fixed-price delivery order is funded through the Defense Logistics Agency's Medical Supply Chain and is scheduled for completion by September 26, 2025. The contract carries no set-aside designation, reflecting AmerisourceBergen's...